Congress Trades

VTRSViatris Inc.

Healthcare · Drug Manufacturers - Specialty & GenericNasdaqStockMkt cap $19.2B
Disclosed trades
23
0 in 30d · 0 in 90d
Politicians
11
Last trade Nov 18, 2025
Buys
8
$88.5K at range midpoints
Sells
14
$3.3M at range midpoints

Closing price · 365 days

Sep 24, 2025 – Sep 23, 2026

Monthly buys vs sells · 24 months

Counts of disclosed transactions
  • Buys
  • Sells (incl. partial)

Politicians who traded it

3 hold it now Estimated
Politicians who traded VTRS
PoliticianSeatTradesBuysSellsBought (mid)Sold (mid)Last tradeEst. position Estimated
RChris JacobsHouse · NY-27321$40.5K$8KJul 18, 2022$53.1K
DDaniel S. GoldmanHouse · NY-10312$8K$16KApr 10, 2023—
DGilbert Ray Cisneros, Jr.House · CA-31311$8K$8KNov 18, 2025$12.8K
RScott FranklinHouse · FL-18303$0$3.2MMay 20, 2021—
DEarl BlumenauerHouse · OR-03211$8K$8KMar 14, 2022—
DKathy E. ManningHouse · NC-06211$8K$8KApr 30, 2021—
RRobert P. Bresnahan, Jr.House · PA-08211$8K$8KApr 8, 2025—
RTommy TubervilleSenate · AL202$0$16KAug 1, 2022—
RCarol D. MillerHouse · WV-01101$0$8KMar 4, 2021—
DJosh GottheimerHouse · NJ-05110$8K$0Nov 19, 2020$7.6K
RPeter MeijerHouse · MI-03101$0$8KFeb 16, 2021—

Recent trades

Disclosed trades
PoliticianTickerAssetTypeOwnerAmountTradedFiledSource
DGilbert Ray Cisneros, Jr.VTRSViatris Inc. - Common Stock (VTRS)BuySelf$1,001 - $15,000Nov 18, 2025Dec 15, 202527dFiling
RRobert P. Bresnahan, Jr.VTRSViatris Inc. - Common Stock (VTRS)SellSelf$1,001 - $15,000Apr 8, 2025May 8, 202530dFiling
DGilbert Ray Cisneros, Jr.VTRSViatris Inc. - Common Stock (VTRS)PartialSelf$1,001 - $15,000Mar 31, 2025Apr 7, 20257dFiling
RRobert P. Bresnahan, Jr.VTRSViatris Inc. - Common Stock (VTRS)BuySelf$1,001 - $15,000Feb 25, 2025Mar 27, 202530dFiling
DDaniel S. GoldmanVTRSViatris Inc. (VTRS)PartialSelf$1,001 - $15,000Apr 10, 2023May 19, 202339dFiling
DDaniel S. GoldmanVTRSViatris Inc. (VTRS)PartialSelf$1,001 - $15,000Mar 6, 2023Apr 17, 202342dFiling
DDaniel S. GoldmanVTRSViatris Inc. (VTRS)BuySelf$1,001 - $15,000Jan 31, 2023Feb 24, 202324dFiling
RTommy TubervilleVTRSViatris Inc. - Common StockSellSelf$1,001 - $15,000Aug 1, 2022Sep 15, 202245dFiling
RChris JacobsVTRSViatris Inc. - Common Stock When Issued (VTRSV)SellReviewSelf$1,001 - $15,000Jul 18, 2022Sep 9, 202253dFiling
RCarol D. MillerVTRSViatris Inc. (VTRS)SellSpouse$1,001 - $15,000Mar 4, 2021Sep 2, 2022547dFiling
RChris JacobsVTRSViatris Inc. - Common Stock When Issued (VTRSV)BuyReviewSelf$1,001 - $15,000Jun 21, 2022Jul 28, 202237dFiling
RChris JacobsVTRSViatris Inc. - Common Stock When Issued (VTRSV)BuyReviewSelf$15,001 - $50,000Jun 16, 2022Jul 28, 202242dFiling
DEarl BlumenauerVTRSViatris Inc. (VTRS)SellSelf$1,001 - $15,000Mar 14, 2022Apr 1, 202218dFiling
DEarl BlumenauerVTRSViatris Inc. (VTRS)BuySelf$1,001 - $15,000Feb 24, 2022Apr 1, 202236dFiling
RTommy TubervilleVTRSViatris Inc. - Common StockSellJoint$1,001 - $15,000Jan 13, 2022Feb 14, 202232dFiling
RScott FranklinVTRSViatris Inc Common StockSellJoint$1,001 - $15,000May 20, 2021Jun 15, 202126dFilingOCR
RScott FranklinVTRSViatris Inc Common StockSellSelf$100,001 - $250,000May 20, 2021Jun 8, 202119dFilingOCR
RScott FranklinVTRSViatris Inc Common StockSellSelf$1,000,001 - $5,000,000May 20, 2021Jun 8, 202119dFilingOCR
DKathy E. ManningVTRSViatris Inc. (VTRS)PartialSelf$1,001 - $15,000Apr 30, 2021May 6, 20216dFiling
RPeter MeijerVTRSViatris Inc. (VTRS)SellSelf$1,001 - $15,000Feb 16, 2021Mar 16, 202128dFiling
DKathy E. ManningVTRSViatris Inc. (VTRS)BuySelf$1,001 - $15,000Jan 15, 2021Feb 4, 202120dFiling
DGilbert Ray Cisneros, Jr.VTRSViatris Inc. (VTRS)ExchangeSelf$1,001 - $15,000Nov 17, 2020Dec 15, 202028dFiling
DJosh GottheimerVTRSViatris Inc. (VTRS)BuyJoint$1,001 - $15,000Nov 19, 2020Dec 9, 202020dFiling

Insider activity Filed

Insiders
24
Pharmaceutical Preparations
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
1
$809.8K sold
Net · 90d
-$809.8K
-$1.1M net over 12 months · last Aug 15, 2026
Insider transactions as filed on SEC Form 4
DateInsiderKindSecuritySharesPriceValuePost-holdingsD/I10b5-1Source
Aug 15, 2026filed Aug 18, 2026Andrew EnriettiSee RemarksExerciseDividend Equivalent Unitsderiv.−998.36$0.00—1,997D—4
Aug 15, 2026filed Aug 18, 2026Andrew EnriettiSee RemarksExerciseRestricted Stock Unitsderiv.−25,134$0.00—50,267D—4
Aug 15, 2026filed Aug 18, 2026Andrew EnriettiSee RemarksWithholdingCommon Stock−435$16.23$7,060234,444D—4
Aug 15, 2026filed Aug 18, 2026Andrew EnriettiSee RemarksExerciseCommon Stock999$0.00$0234,879D—4
Aug 15, 2026filed Aug 18, 2026Andrew EnriettiSee RemarksWithholdingCommon Stock−10,931$16.23$177,410233,880D—4
Aug 15, 2026filed Aug 18, 2026Andrew EnriettiSee RemarksExerciseCommon Stock25,134$0.00$0244,811D—4
Jun 30, 2026filed Jul 1, 2026David S SimmonsAwardDeferred Stock Unitsderiv.2,362$15.88—2,362D—4
Jun 30, 2026filed Jul 1, 2026Leo Frans GroothuisAwardDeferred Stock Unitsderiv.2,756$15.88—2,756D—4
Jun 25, 2026filed Jun 26, 2026Paul CampbellSee RemarksSaleCommon Stock−50,076$16.17$809,784316,212D10b5-14
Apr 15, 2026filed Apr 16, 2026Corinne Le GoffChief Commercial OfficerExerciseDividend Equivalent Unitsderiv.−3,643.83$0.00—0D—4

Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).

Unusual activity Estimated